Advaxis receives Research coverage
Advaxis Inc.,, a developmental biotechnology company, receives equity research coverage from Crystal Research Associates, LLC, an independent research firm out of New York City.
AdnaGen, a subsidiary of OncoVista Innovative Therapies, a biotechnology company, has entered into an option agreement to license specific antibodies to KellBenx, a New York-based biotech firm.